HKD 1.51
(0.67%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 120.07 Million | 234.07 Million | -122.52 Million | -125.22 Million | 20.19 Million | 19.8 Million |
Net Income | -6.78 Million | 274.62 Million | 130.71 Million | -5.17 Million | 29.1 Million | 91.25 Million |
Depreciation & Amortization | 13.87 Million | 11.73 Million | 8.69 Million | 9.47 Million | 9.7 Million | 16.1 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 81.74 Million | -430.22 Million | -322.54 Million | -215.76 Million | 2.38 Million | -77.92 Million |
Other non-cash items | 31.24 Million | 377.94 Million | 60.61 Million | 86.23 Million | -21 Million | -9.63 Million |
Investing Cash Flow | -140.43 Million | -197.72 Million | -164.18 Million | -150.75 Million | -153.88 Million | -19.35 Million |
Investments in PPE | -139.87 Million | -274.36 Million | -214.99 Million | -88.08 Million | -57.36 Million | -39.06 Million |
Acquisitions | -580 Thousand | -248 Thousand | -714 Thousand | - | - | - |
Investment purchases | -476 Thousand | -2.1 Million | -1.66 Million | -689 Thousand | - | - |
Sales/Maturities of investments | 108 Thousand | 2.35 Million | 2.37 Million | - | - | - |
Other Investing Activities | 393 Thousand | 76.64 Million | 50.81 Million | -61.97 Million | -96.52 Million | 19.7 Million |
Financing Cash Flow | -4.97 Million | 9.07 Million | 284.98 Million | 303.33 Million | 139.24 Million | -4.04 Million |
Debt repayment | -450.41 Million | -563.03 Million | -414.57 Million | -475.61 Million | -294.73 Million | -211.73 Million |
Dividends payments | - | - | - | -1.8 Million | -54.65 Million | -8.96 Million |
Common Stock Repurchased | -23.02 Million | - | - | 362.86 Million | - | - |
Common Stock Issuance | - | - | - | 112.75 Million | - | - |
Other Financing Activities | -68.54 Million | 572.1 Million | 699.56 Million | 305.13 Million | 488.63 Million | 216.64 Million |
Accounts receivables | -492.34 Million | -412.49 Million | -231.12 Million | -206.59 Million | -10.79 Million | -17.92 Million |
Accounts payables | 492.34 Million | -285.58 Million | 48.79 Million | -41.37 Million | 34.08 Million | 17.92 Million |
Inventory | 77.98 Million | -17.73 Million | -91.41 Million | -9.16 Million | 13.18 Million | -12.32 Million |
Other working capital | 3.75 Million | 285.58 Million | -48.79 Million | 41.37 Million | -34.08 Million | -65.6 Million |
Cash at beginning of period | 103.18 Million | 58.02 Million | 61.9 Million | 35.71 Million | 30.26 Million | 34.62 Million |
Cash at end of period | 77.39 Million | 103.18 Million | 58.02 Million | 61.9 Million | 35.71 Million | 30.26 Million |
Capital Expenditure | -139.87 Million | -274.36 Million | -214.99 Million | -88.08 Million | -57.36 Million | -39.06 Million |
Effect of forex changes on cash | -457 Thousand | -272 Thousand | -2.16 Million | -1.17 Million | -93 Thousand | -761 Thousand |
Net cash flow / Change in cash | -25.79 Million | 45.15 Million | -3.88 Million | 26.19 Million | 5.45 Million | -4.35 Million |
Free Cash Flow | -19.8 Million | -40.28 Million | -337.51 Million | -213.31 Million | -37.17 Million | -19.25 Million |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 4.44 Million | 1.84 Million | -6.78 Million | 881 Thousand | 274.62 Million | 103.82 Million |
Depreciation & Amortization | 39.43 Million | -17.82 Million | 13.87 Million | 31.7 Million | 11.73 Million | -10.18 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 62 Million | 81.74 Million | - | -430.22 Million | -144.64 Million |
Other non-cash items | -3.95 Million | 47.05 Million | 31.24 Million | -5.59 Million | 377.94 Million | 371.62 Million |
Investing Cash Flow | -72.36 Million | -40.48 Million | -140.43 Million | -99.94 Million | -197.72 Million | -92.98 Million |
Investments in PPE | -67.73 Million | -63.96 Million | -139.87 Million | -75.91 Million | -274.36 Million | -166.67 Million |
Acquisitions | - | - | -580 Thousand | - | -248 Thousand | - |
Investment purchases | - | - | -476 Thousand | - | -2.1 Million | - |
Sales/Maturities of investments | - | - | 108 Thousand | - | 2.35 Million | - |
Other Investing Activities | -4.62 Million | 23.48 Million | 393 Thousand | -24.03 Million | 76.64 Million | 73.69 Million |
Financing Cash Flow | 54.1 Million | -73.79 Million | -4.97 Million | 68.82 Million | 9.07 Million | -195.54 Million |
Debt repayment | -72.2 Million | - | -450.41 Million | -84.93 Million | -563.03 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | -23.02 Million | -23.02 Million | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -18.09 Million | -50.77 Million | -68.54 Million | -16.11 Million | 572.1 Million | -195.54 Million |
Accounts receivables | - | -492.34 Million | -492.34 Million | - | -412.49 Million | -412.49 Million |
Accounts payables | - | - | 492.34 Million | - | -285.58 Million | - |
Inventory | - | 77.98 Million | 77.98 Million | - | -17.73 Million | -17.73 Million |
Other working capital | - | 476.37 Million | 3.75 Million | - | 285.58 Million | 285.58 Million |
Cash at beginning of period | 77.39 Million | 101.14 Million | 103.18 Million | 103.18 Million | 58.02 Million | 70.92 Million |
Cash at end of period | 96.98 Million | 77.39 Million | 77.39 Million | 101.14 Million | 103.18 Million | 103.18 Million |
Capital Expenditure | -67.73 Million | -63.96 Million | -139.87 Million | -75.91 Million | -274.36 Million | -166.67 Million |
Effect of forex changes on cash | -2.06 Million | -2.55 Million | -457 Thousand | 2.09 Million | -272 Thousand | 164 Thousand |
Net cash flow / Change in cash | 19.59 Million | -23.74 Million | -25.79 Million | -2.04 Million | 45.15 Million | 32.26 Million |
Free Cash Flow | -27.81 Million | 29.11 Million | -19.8 Million | -48.92 Million | -40.28 Million | 153.95 Million |
CAST
SMSMED
FMCXF
SEM
JG
600460